Tirzepatide - a dual GIP and GLP-1 receptor agonist prescribed for chronic weight management and Type 2 diabetes care, currently among the most discussed therapies in the obesity care category
We will answer the top 10 questions people have about these treatments, providing you with the information you need to make an informed decision about your weight loss journey
In a previous metanalysis, GLP-1 agonists were found to improve hepatic parameters in patients with NAFLD [38]
For example, if your health insurance plan has a $1,000 deductible, you must pay the first $1,000 of your medical expenses out of your pocket before your insurance company starts to cover any costs for the year
Clearly, if you want your first dose in hand quickly, Peak is the no-brainer